Mainly Cloudy 31°. Wind Chill: 21°. Wind: W 10 mph.
Trending: AB InBev to acquire 85% stake in beverage maker BeatBox for $490 million
HomeNewsNationalHealth ( Page 16)

Health

Subscribe to the Health News Feed.
SHARE NOW
by

Researchers move closer to matching patients with GLP-1 drug that works best for them

By Nancy Lapid (Reuters) -U.S. researchers are beginning to identify clinical characteristics that distinguish "super responders" to GLP-1 weight-loss drugs like Wegovy and Zepbound from patients who lose only moderate amounts of weight at best, according to a report published online ahead of peer review. The ...
by

US jury convicts founder of ADHD startup in Adderall fraud scheme

By Jonathan Stempel (Reuters) -The founder and a former top doctor at Done Global were convicted by a San Francisco jury of conspiring to distribute Adderall and other stimulants, in the first federal prosecution of alleged illegal drug distribution by a telehealth company. Ruthia He, who ...
by

Abbott is weighing takeover of Exact Sciences, Bloomberg News reports

(Reuters) -Medical device maker Abbott Laboratories is nearing a potential takeover of cancer test maker Exact Sciences Corp, Bloomberg News reported on Wednesday, citing people familiar with the matter. The deal could be announced in the coming days and deliberations are ongoing, which could ...
by

US FDA approves Bayer’s lung cancer drug

(Reuters) -The U.S. Food and Drug Administration on Wednesday approved Bayer's drug for patients with a type of lung cancer. The drug, branded as Hyrnuo, was approved for adults with non-squamous non-small cell lung cancer that has advanced or spread to other parts of the ...
by

Activist Browning West urges contact lens maker Cooper Cos to refresh board or face proxy fight

By Svea Herbst-Bayliss NEW YORK (Reuters) -Investor Browning West wants Cooper Cos to add four newcomers to its board to improve the medical device maker's operations and signaled it is ready to run a proxy contest if the company should balk, according to a letter ...
by

Pfizer in $41.5 million settlement with Texas over ADHD drug

(Reuters) -Pfizer and supplier Tris Pharma reached a $41.5 million settlement with Texas to resolve claims over alleged quality control lapses in medicine to treat attention deficit hyperactivity disorder in children, Texas Attorney General Ken Paxton said on Wednesday. (Reporting by Jonathan Stempel in New ...
https://www.menards.com/main/home.html
by

Merck’s oral HIV treatment non-inferior to Gilead’s Biktarvy in late-stage trial 

(Reuters) -Merck said on Wednesday that its experimental oral HIV treatment was not inferior to Gilead's top-selling HIV drug Biktarvy in a late-stage study in adults with HIV who had not previously received treatment. The Rahway, New Jersey-based company was testing its oral, two-drug regimen ...
by

Health Rounds: High blood pressure among children doubles; obesity may be driving trend

(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.) By Nancy Lapid (Reuters) -The worldwide prevalence of high blood pressure in children and adolescents nearly doubled between 2000 and 2020, new research shows, with obesity ...
by

Teva seeks startups to help solve global pharmaceutical challenges

By Steven Scheer JERUSALEM (Reuters) -Teva Pharmaceutical Industries said on Wednesday it was calling on startups to join its new platform to develop technologies to deal with a host of challenges facing Teva and the global pharmaceuticals industry. Called Teva Rise, the company's open innovation platform ...
by

Agios Pharma reports mixed results in late-stage study for sickle cell disease drug

(Reuters) -Agios Pharmaceuticals said on Wednesday its sickle cell drug met one of its two main goals in a late-stage study of patients aged 16 and older, but failed to show a statistically significant reduction in pain crises. Shares of the Cambridge, Massachusetts-based drugmaker ...
by

Moderna to complete US mRNA manufacturing network with $140 million investment

(Reuters) -Moderna said on Wednesday it would now operate full end-to-end manufacturing for its mRNA medicines in the U.S., marking a major step in strengthening the company's domestic production network. The Cambridge-based company plans to invest more than $140 million to add the final manufacturing ...
by

Be Well: Breaking down fiber, the next food fad

U.S. consumers who have had their fill of finding protein added to everything from cereal to ice cream are about to meet the next big food fad: fiber. Americans have been boosting their protein intake for years; even Pop-Tarts and Starbucks are selling protein-enhanced products. ...
First Previous121314151617181920Next Last